Enhancing vector bioprocess scalability 2022

Vectors

Enhancing vector bioprocess scalability 2022

Enhancing vector bioprocess scalability 2022

Filter by ContentType

Key considerations when adopting Droplet Digital PCR for viral vector manufacture

Key considerations when adopting Droplet Digital PCR for viral vector manufacture

Mark White
24 February 2022
FastFacts
 Residual DNA testing in viral vector manufacture: exploring the challenges and solutions

Residual DNA testing in viral vector manufacture: exploring the challenges and solutions

Ilaria Scarfone, Mike Brewer
22 February 2022
Podcast
 Optimization of anion exchange purification for the large-scale production of plasmid DNA for gene therapy and DNA vaccine applications

Optimization of anion exchange purification for the large-scale production of plasmid DNA for gene therapy and DNA vaccine applications

Jenny England
15 February 2022
FastFacts
 Commercial-scale lentiviral vector manufacturing: is the myth busted?

Commercial-scale lentiviral vector manufacturing: is the myth busted?

Hanna Leinonen
31 January 2022
Expert Insight
 Tackling scalability challenges in AAV manufacture

Tackling scalability challenges in AAV manufacture

Kyle Grant
31 January 2022
Interview
 Platform optimization for efficient AAV purification: insights from a CDMO

Platform optimization for efficient AAV purification: insights from a CDMO

Vincent Ravault, Nicolas Laroudie
23 January 2022
Innovator Insight

Other editions


<< Back to Vectors channel